These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22327368)

  • 1. Closed-loop artificial pancreas: current studies and promise for the future.
    Weinzimer SA
    Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):88-92. PubMed ID: 22327368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin patch pumps: their development and future in closed-loop systems.
    Anhalt H; Bohannon NJ
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1(Suppl 1):S51-8. PubMed ID: 20515308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
    Ward WK; Castle JR; El Youssef J
    J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
    Davis T; Salahi A; Welsh JB; Bailey TS
    Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent closed-loop blood glucose control for people with type 1 diabetes on multiple daily injections.
    Estremera E; Beneyto A; Cabrera A; Contreras I; Vehí J
    Comput Methods Programs Biomed; 2023 Jun; 236():107568. PubMed ID: 37137221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Insulin Delivery in Adults.
    Boughton CK; Hovorka R
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):167-178. PubMed ID: 31980116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated blood glucose control in type 1 diabetes: A review of progress and challenges.
    Bertachi A; Ramkissoon CM; Bondia J; Vehí J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):172-181. PubMed ID: 29279252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
    Lal RA; Ekhlaspour L; Hood K; Buckingham B
    Endocr Rev; 2019 Dec; 40(6):1521-1546. PubMed ID: 31276160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices.
    Kudva YC; Carter RE; Cobelli C; Basu R; Basu A
    Diabetes Care; 2014; 37(5):1184-90. PubMed ID: 24757225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in development of an artificial pancreas.
    Klonoff DC; Cobelli C; Kovatchev B; Zisser HC
    J Diabetes Sci Technol; 2009 Sep; 3(5):1002-4. PubMed ID: 20144412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing closed-loop home: recent advances in closed-loop insulin delivery.
    Thabit H; Hovorka R
    Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):95-101. PubMed ID: 24569550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.